Clinical Trials Browser

Phase 2 × Leukemia × Dosage Forms × Clear all

NCT00042341 2022-05-27

Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00042354 2015-03-05

Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) Patients

Phase 2 Completed

Other hematologic neoplasm

Leukemia